A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer — Stella

Recruiting

Back to DTC - Differentiated Thyroid Cancer trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Japan

National Cancer Center Hospital East, Kashiwa

Key details

Phase

Early testing

Sponsor

Alpha Fusion Inc.

Enrollment target

~38 participants

Started

January 2026

Primary completion

July 2028

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov